BioNTech SE Stock Price Patterns
| BNTX Stock | USD 86.81 -1.60 -1.81% |
Momentum
Sell Stretched
Oversold | Overbought |
Attention patterns for BioNTech SE are aligned with recent price response. This information is presented as reference data. Sentiment context for BioNTech is drawn from options positioning and short interest patterns. The dataset reflects publicly available market data.
BioNTech Short Interest Pattern
Short interest patterns for BioNTech add a positioning layer to sentiment analysis. The figures are grounded in exchange-reported price and volume records.
Hype and Price Pattern for BioNTech SE
This sentiment view tracks attention patterns around BioNTech and relates them to price behavior. All metrics are computed from historical trading data across available periods.
How sentiment and price interact for BioNTech is presented as informational context. This context is presented for informational purposes and should be read alongside other signals.
BioNTech Implied Volatility | 0.53 |
Implied volatility for BioNTech provides a market-based measure of expected variability. The reading is provided as context for near-term price variability.
This module tracks attention around BioNTech and presents the data alongside performance cues. All information is presented as neutral analytical context.
BioNTech after-hype prediction price | $ 87.21 |
The module provides attention context in addition to forecasting models and technical indicators. This multi-signal approach helps frame attention patterns within a broader context.
Rule 16 Summary for current BioNTech contract
Under Rule 16, the annualized implied volatility for 2026-06-18 options translates to a daily move of about 0.0331%. With BioNTech trading near $ 86.81, this corresponds to about $ 0.03 per day.
BioNTech | Build portfolio with BioNTech Stock |
The concept of mean reversion suggests that BioNTech's price will eventually return toward its long-run average. Positions sized too aggressively against the trend can suffer sustained losses before reversion occurs in BioNTech. The mean reversion framework for BioNTech is built on the premise that markets are not perfectly efficient.
After-Hype Price Density Analysis
This probability density chart for BioNTech shows how predicted future prices are distributed across outcomes. BioNTech's price distribution after major news events tends to be skewed, with larger potential downside moves for established companies. This distribution for BioNTech incorporates BioNTech's historical volatility, mean reversion tendencies, and jump risk.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Using BioNTech's historical news impact data, we estimate the likely price corridor after a significant headline. BioNTech's after-hype downside and upside margins for the prediction period are 83.54 and 90.88, respectively. Predictive accuracy varies across different news categories and market regimes for BioNTech.
Current Value
Macroaxis estimates the after-hype price of BioNTech SE across a 3 months horizon to evaluate where the instrument could settle once headline distortion subsides. The objective is to separate event-driven enthusiasm from a more stable price path once the market absorbs the catalyst.
Price Outlook Analysis
Big price swings in a Company such as BioNTech are not always tied to earnings or company news. Social media buzz and retail interest in BioNTech can add another layer of momentum to fund flows.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 3.65 | 0.06 | 0.14 | 38 Events | 7 Events | In 38 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
86.81 | 87.21 | 0.06 |
|
Hype Timeline
BioNTech SE is currently traded for 86.81. The company has historical hype elasticity of 0.06, and average elasticity to hype of competition of 0.14. BioNTech is anticipated to increase in value after the next headline, with the price projected to jump to 87.21 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.06%, whereas the daily expected return is currently at -0.08%. The volatility of related hype on BioNTech is about 201.99%, with the expected price after the next announcement by competition of 86.95. The company reported previous year's revenue of 2.76 B. Net Loss for the year was -1.09 B with profit before overhead, payroll, taxes, and interest of 2.26 B. Given the investment horizon of 90 days the next anticipated press release will be in 38 days. Model-based validation of BioNTech's projections is available through BioNTech Basic Forecasting Models.Related Hype Analysis
Understanding how BioNTech's direct competitors react to news provides context for anticipating sector-wide sentiment shifts. Peer hype analysis distinguishes between sector-level sentiment shifts and BioNTech-specific developments. News about regulatory changes, technological disruptions, or macro shifts can affect BioNTech's entire competitive landscape.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INCY | Incyte | -1.50 | 10 per month | 0.00 | -0.01 | 3.67 | -2.92 | 13.76 | |
| GMAB | Genmab AS | 0.61 | 10 per month | 0.00 | -0.09 | 3.31 | -4.22 | 11.88 | |
| UTHR | United Therapeutics | 14.56 | 11 per month | 1.58 | 0.06 | 2.19 | -2.52 | 18.91 | |
| TEVA | Teva Pharma Industries | 0.97 | 7 per month | 0.00 | 0.0026 | 3.05 | -3.52 | 8.64 | |
| DXCM | DexCom Inc | -1.62 | 10 per month | 1.63 | 0.03 | 3.31 | -2.85 | 11.25 | |
| NTRA | Natera Inc | 4.86 | 13 per month | 0.00 | -0.04 | 3.71 | -3.78 | 14.46 | |
| PHG | Koninklijke Philips NV | -0.61 | 8 per month | 1.93 | 0.04 | 2.43 | -2.63 | 15.21 | |
| STE | STERIS plc | -0.23 | 14 per month | 0.00 | -0.07 | 1.98 | -3.35 | 10.43 | |
| RPRX | Royalty Pharma Plc | 0.47 | 18 per month | 0.84 | 0.30 | 2.01 | -1.34 | 6.42 | |
| BIIB | Biogen Inc | 0.56 | 6 per month | 1.77 | 0.08 | 4.38 | -2.93 | 12.20 |
BioNTech Additional Predictive Modules
Price prediction tools for BioNTech synthesize indicator signals with time-series patterns to model directional expectations. Time-series models tend to perform better when fed clean, stationary data with consistent periodicity.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for BioNTech evaluates news tone, positioning, and narrative momentum. Narrative divergence can signal instability and regime transition risk. BioNTech has a market cap of 22.44 B, P/E of 5.19, ROE of -5.88%.
Unless otherwise specified, data for BioNTech SE is compiled from periodic company reporting and market reference feeds and standardized for comparability. Where analyst coverage exists, consensus estimates are factored in. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Popular Tools for BioNTech Stock analysis
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |